Relationship between Galectin-3 Levels and Mineralocorticoid Receptor Antagonist Use in Heart Failure: Analysis from the HF-ACTION Study

BACKGROUND: Galectin-3 (Gal-3) is a marker of myocardial fibrosis, and elevated levels are associated with adverse outcomes. Mineralocorticoid receptor antagonists (MRA) modulate cardiac fibrosis in HF patients, and have been shown to improve long term outcomes. We examined whether treatment effects...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Fiuzat, Mona, Schulte, Phillip J., Felker, G. Michael, Ahmad, Tariq, Neely, Megan, Adams, Kirkwood F., Donahue, Mark P., Kraus, William E., Piña, Ileana L., Whellan, David J., O’Connor, Christopher M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3930443/
https://ncbi.nlm.nih.gov/pubmed/24304938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cardfail.2013.11.011
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky